Patents by Inventor Kazuhiro Kobuke

Kazuhiro Kobuke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
    Patent number: 7998491
    Abstract: The invention discloses a useful and novel factor (polypeptide) which plays an important role for morbid vascular smooth muscle in restenosis after percutaneous transluminal coronary angioplasty (PTCA) and arterial sclerosis in the field of cardiovascular system.
    Type: Grant
    Filed: June 21, 2010
    Date of Patent: August 16, 2011
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Tasuku Honjo, Kei Tashiro, Kazuhiro Kobuke
  • NOVEL POLYPEPTIDE ESDN, POLYNUCLEOTIDES ENCODING THE POLYPEPTIDE, AND UTILITY OF THE POLYPEPTIDE
    Publication number: 20110020351
    Abstract: The invention discloses a useful and novel factor (polypeptide) which plays an important role for morbid vascular smooth muscle in restenosis after percutaneous transluminal coronary angioplasty (PTCA) and arterial sclerosis in the field of cardiovascular system.
    Type: Application
    Filed: June 21, 2010
    Publication date: January 27, 2011
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: TASUKU HONJO, KEI TASHIRO, KAZUHIRO KOBUKE
  • Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
    Patent number: 7794975
    Abstract: The invention discloses a useful and novel factor (polypeptide) which plays an important role for morbid vascular smooth muscle in restenosis after percutaneous transluminal coronany angioplasty (PTCA) and arterial sclerosis in the field of cardiovascular system.
    Type: Grant
    Filed: March 19, 2007
    Date of Patent: September 14, 2010
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Tasuku Honjo, Kei Tashiro, Kazuhiro Kobuke
  • NOVEL POLYPEPTIDE ESDN, POLYNUCLEOTIDES ENCODING THE POLYPEPTIDE, AND UTILITY OF THE POLYPEPTIDE
    Publication number: 20070172892
    Abstract: The invention discloses a useful and novel factor (polypeptide) which plays an important role for morbid vascular smooth muscle in restenosis after percutaneous transluminal coronany angioplasty (PTCA) and arterial sclerosis in the field of cardiovascular system.
    Type: Application
    Filed: March 19, 2007
    Publication date: July 26, 2007
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Tasuku HONJO, Kei TASHIRO, Kazuhiro KOBUKE
  • Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
    Patent number: 7217786
    Abstract: The invention discloses a useful and novel factor (polypeptide) which plays an important role for morbid vascular smooth muscle in restenosis after percutaneous transluminal coronany angioplasty (PTCA) and arterial sclerosis in the field of cardiovascular system.
    Type: Grant
    Filed: February 11, 2005
    Date of Patent: May 15, 2007
    Assignee: ONO Pharmaceutical Co., Ltd.
    Inventors: Tasuku Honjo, Kei Tashiro, Kazuhiro Kobuke
  • Novel polypeptide ESDN, polynuleotides encoding the polypeptide, and utility of the polypeptide
    Publication number: 20050202481
    Abstract: The invention discloses a useful and novel factor (polypeptide) which plays an important role for morbid vascular smooth muscle in restenosis after percutaneous transluminal coronany angioplasty (PTCA) and arterial sclerosis in the field of cardiovascular system.
    Type: Application
    Filed: February 11, 2005
    Publication date: September 15, 2005
    Inventors: Tasuku Honjo, Kei Tashiro, Kazuhiro Kobuke
  • Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
    Patent number: 6900031
    Abstract: The invention discloses a useful and novel factor (polypeptide) which plays an important role for morbid vascular smooth muscle in restenosis after percutaneous transluminal coronany angioplasty (PTCA) and arterial sclerosis in the field of cardiovascular system.
    Type: Grant
    Filed: July 10, 2002
    Date of Patent: May 31, 2005
    Assignee: ONO Pharmaceutical Co., Ltd.
    Inventors: Tasuku Honjo, Kei Tashiro, Kazuhiro Kobuke
  • Novel polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
    Publication number: 20030129697
    Abstract: The invention discloses a useful and novel factor (polypeptide) which plays an important role for morbid vascular smooth muscle in restenosis after percutaneous transluminal coronany angioplasty (PTCA) and arterial sclerosis in the field of cardiovascular system.
    Type: Application
    Filed: July 10, 2002
    Publication date: July 10, 2003
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Tasuku Honjo, Kei Tashiro, Kazuhiro Kobuke